https://doi.org/10.1186/1479-5876-11-307
J
Johannes Laengle
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
47
Papers
722
Citations
14
h-index
15
i10-index
Johannes Laengle is an academic researcher from Fachhochschule Wiener Neustadt. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Colorectal Cancer Treatments and Studies & Colorectal Cancer Surgical Treatments. The author has an h-index of 14, co-authored 40 publications.
ORCID: 0000-0003-4771-1398Papers by this author
worksTrastuzumab mediates antibody-dependent cell-mediated cytotoxicity and phagocytosis to the same extent in both adjuvant and metastatic HER2/neu breast cancer patients
2013 · Journal of Translational Medicine · 182 citations
From threat to cure: understanding of virus-induced cell death leads to highly immunogenic oncolytic influenza viruses
2020 · Cell Death Discovery · 38 citations
https://doi.org/10.1038/s41420-020-0284-1
Dysfunctional tumor-infiltrating Vδ1 + T lymphocytes in microsatellite-stable colorectal cancer
2024 · Nature Communications · 23 citations
https://doi.org/10.1038/s41467-024-51025-1
Glucagon-like peptide-1 and -2: potential regulators of lipid metabolism during liver regeneration
2024 · HPB · 0 citations
https://doi.org/10.1016/j.hpb.2024.04.166
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat